Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 2,639 $ 6,888
Trading marketable securities 10,225 9,150
Available-for-sale securities (amortized cost of $0 and $1,502, respectively) 0 1,495
Prepaid expenses and other current assets 564 789
Total Current Assets 13,428 18,322
Operating lease right-of-use assets 29 60
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 15,499 20,424
Current Liabilities    
Accounts payable and accrued liabilities 840 905
Due to related parties 49 53
Operating lease liabilities - current portion 32 40
Total Current Liabilities 921 998
Operating lease liabilities 0 23
TOTAL LIABILITIES 921 1,021
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized, as of September 30, 2023 and December 31, 2022 3,162,354 and 2,855,688 shares issued and outstanding as of September 30, 2023 and December 31, 2022 3 3
Additional paid-in capital 52,011 50,675
Accumulated deficit (37,237) (31,021)
Accumulated other comprehensive loss (199) (254)
TOTAL STOCKHOLDERS' EQUITY 14,578 19,403
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 15,499 $ 20,424